Mariner LLC cut its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 2.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 88,391 shares of the company's stock after selling 2,394 shares during the quarter. Mariner LLC owned approximately 0.07% of Clorox worth $14,356,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of CLX. California Public Employees Retirement System lifted its holdings in shares of Clorox by 1.3% in the 4th quarter. California Public Employees Retirement System now owns 565,810 shares of the company's stock worth $91,893,000 after purchasing an additional 6,987 shares in the last quarter. Fifth Third Wealth Advisors LLC acquired a new position in Clorox during the fourth quarter worth $204,000. Apollon Wealth Management LLC lifted its stake in shares of Clorox by 119.6% in the fourth quarter. Apollon Wealth Management LLC now owns 3,364 shares of the company's stock valued at $546,000 after buying an additional 1,832 shares in the last quarter. Miracle Mile Advisors LLC acquired a new position in shares of Clorox during the fourth quarter valued at about $1,566,000. Finally, SG Americas Securities LLC increased its position in shares of Clorox by 489.2% during the fourth quarter. SG Americas Securities LLC now owns 115,252 shares of the company's stock worth $18,718,000 after acquiring an additional 95,691 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the company. Evercore ISI lifted their price target on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Wells Fargo & Company cut their target price on Clorox from $155.00 to $145.00 and set an "equal weight" rating on the stock in a research report on Wednesday. Barclays lowered their price target on Clorox from $139.00 to $134.00 and set an "underweight" rating for the company in a research report on Friday, April 11th. JPMorgan Chase & Co. cut their price objective on shares of Clorox from $173.00 to $151.00 and set a "neutral" rating on the stock in a report on Friday, April 11th. Finally, Citigroup lowered their target price on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a report on Monday. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $153.83.
Get Our Latest Research Report on Clorox
Clorox Stock Up 2.0 %
CLX opened at $139.60 on Friday. The company's 50-day moving average price is $146.74 and its two-hundred day moving average price is $156.63. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The stock has a market cap of $17.20 billion, a price-to-earnings ratio of 38.14, a PEG ratio of 2.62 and a beta of 0.61.
Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the business earned $2.16 earnings per share. As a group, equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.50%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.
About Clorox
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.